tiprankstipranks
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market

Aprea Therapeutics (APRE) Ownership - Who Owns Aprea Therapeutics?

427 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 14, 2024
John P. Hamill
Srvp/cfo/prin Fin & Acct Ofcr
Bought$7363
Mar 14, 2024
Oren Gilad
President & Ceo,director
Bought$14580
Mar 14, 2024Bought$50009
Mar 14, 2024Bought$50009

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
114,842Institution2.11%616,702
33,552Institution0.62%180,174
17,552Institution0.32%94,254
3,220Institution0.06%17,291
2,358Institution0.04%12,662
1,136Institution0.02%6,100

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
33,552Institution0.62%180,174
17,552Institution0.32%94,254
2,358Institution0.04%12,662
1,136Institution0.02%6,100

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
86,280Institution1.59%577,213
28,562Institution0.53%191,080
1,700Institution0.03%9,197
1,111Institution0.02%5,911
409Institution<0.01%2,176

FAQ

Who Owns Aprea Therapeutics Inc (APRE)?
Currently, no data Available
What percentage of Aprea Therapeutics Inc (APRE) stock is held by institutional investors?
Currently, no data Available
What percentage of Aprea Therapeutics Inc (APRE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Aprea Therapeutics Inc (APRE)?
Vanguard owns the most shares of Aprea Therapeutics Inc (APRE).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis